{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:40:43Z","timestamp":1791420043012,"version":"4.3.3"},"reference-count":42,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1210\/me.2004-0520","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T00:13:15Z","timestamp":1113523995000},"page":"1646-1653","source":"Crossref","is-referenced-by-count":266,"title":["Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor"],"prefix":"10.1210","volume":"19","author":[{"given":"Wendong","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Biology (W.H., J.Z., M.W., J.L., D.D.M.), Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (W.H., J.Z., M.W., J.L., D.D.M.), Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Washington","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (W.H., J.Z., M.W., J.L., D.D.M.), Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (W.H., J.Z., M.W., J.L., D.D.M.), Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Parant","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, and Department of Molecular Genetics (J.M.P., G.L.), University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, and Department of Molecular Genetics (J.M.P., G.L.), University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (W.H., J.Z., M.W., J.L., D.D.M.), Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041123440692200_R1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","article-title":"PXR, CAR and drug metabolism.","volume":"1","author":"Willson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2019041123440692200_R2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/07853890310008224","article-title":"Drug-activated nuclear receptors CAR and PXR.","volume":"35","author":"Honkakoski","year":"2003","journal-title":"Ann Med"},{"key":"2019041123440692200_R3","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1101\/gad.846800","article-title":"Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR.","volume":"14","author":"Xie","year":"2000","journal-title":"Genes Dev"},{"key":"2019041123440692200_R4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.tpj.6500087","article-title":"Specific and overlapping functions of the nuclear hormone receptors CAR and PXR in xenobiotic response.","volume":"2","author":"Wei","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"2019041123440692200_R5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification.","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol Pharmacol"},{"key":"2019041123440692200_R6","doi-asserted-by":"crossref","first-page":"49517","DOI":"10.1074\/jbc.M409041200","article-title":"The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity.","volume":"279","author":"Zhang","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041123440692200_R7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj2810577","article-title":"Phenobarbital induction of cytochrome P-450 gene expression.","volume":"281","author":"Waxman","year":"1992","journal-title":"Biochem J"},{"key":"2019041123440692200_R8","first-page":"571","article-title":"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity.","volume":"18","author":"Poland","year":"1980","journal-title":"Mol Pharmacol"},{"key":"2019041123440692200_R9","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/MCB.20.9.2951-2958.2000","article-title":"The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene is an agonist ligand for the nuclear receptor CAR.","volume":"20","author":"Tzameli","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041123440692200_R10","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/MCB.21.8.2838-2846.2001","article-title":"The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver.","volume":"21","author":"Zelko","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2019041123440692200_R11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/carcin\/13.10.1893","article-title":"Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA\/2NCr and C57BL\/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344\/NCr rats initiated with N-nitrosodiethylamine.","volume":"13","author":"Diwan","year":"1992","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","article-title":"Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion.","volume":"71","author":"Whysner","year":"1996","journal-title":"Pharmacol Ther"},{"key":"2019041123440692200_R13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0163-7258(98)00058-8","article-title":"The perturbation of apoptosis and mitosis by drugs and xenobiotics.","volume":"82","author":"Hasmall","year":"1999","journal-title":"Pharmacol Ther"},{"key":"2019041123440692200_R14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1191\/096032700701546442","article-title":"Epigenetic mechanisms of chemical carcinogenesis.","volume":"19","author":"Klaunig","year":"2000","journal-title":"Hum Exp Toxicol"},{"key":"2019041123440692200_R15","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","article-title":"The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice.","volume":"64","author":"Yamamoto","year":"2004","journal-title":"Cancer Res"},{"key":"2019041123440692200_R16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/35038112","article-title":"The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.","volume":"407","author":"Wei","year":"2000","journal-title":"Nature"},{"key":"2019041123440692200_R17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/5.4.453","article-title":"Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters.","volume":"5","author":"Bursch","year":"1984","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1042\/bj2890807","article-title":"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression.","volume":"289","author":"Smith","year":"1993","journal-title":"Biochem J"},{"key":"2019041123440692200_R19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/excr.1998.4223","article-title":"Fractionation of rat hepatocyte subpopulations with varying metabolic potential, proliferative capacity, and retroviral gene transfer efficiency.","volume":"244","author":"Rajvanshi","year":"1998","journal-title":"Exp Cell Res"},{"key":"2019041123440692200_R20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<273::AID-MC6>3.0.CO;2-N","article-title":"Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.","volume":"25","author":"Christensen","year":"1999","journal-title":"Mol Carcinog"},{"key":"2019041123440692200_R21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)64709-8","article-title":"Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-bis[2-(3,5-dichloropyridyloxy)] benzene.","volume":"156","author":"Ledda-Columbano","year":"2000","journal-title":"Am J Pathol"},{"key":"2019041123440692200_R22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0168-9525(01)02369-1","article-title":"MDM2: life without p53.","volume":"17","author":"Daujat","year":"2001","journal-title":"Trends Genet"},{"key":"2019041123440692200_R23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/carcin\/bgg185","article-title":"Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions.","volume":"25","author":"Finnberg","year":"2004","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s004320050162","article-title":"The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma.","volume":"124","author":"Qiu","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"2019041123440692200_R25","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/MCB.19.1.864","article-title":"Regulation of the mdm2 oncogene by thyroid hormone receptor.","volume":"19","author":"Qi","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2019041123440692200_R26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/378206a0","article-title":"Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.","volume":"378","author":"Jones","year":"1995","journal-title":"Nature"},{"key":"2019041123440692200_R27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/378203a0","article-title":"Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.","volume":"378","author":"Montes de Oca Luna","year":"1995","journal-title":"Nature"},{"key":"2019041123440692200_R28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4274(00)00299-X","article-title":"Phenobarbitone-induced ploidy changes in liver occur independently of p53.","volume":"119","author":"Martin","year":"2001","journal-title":"Toxicol Lett"},{"key":"2019041123440692200_R29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/carcin\/22.10.1601","article-title":"Inhibition of apoptosis in rat hepatocytes treated with \u2018non-dioxin-like\u2019 polychlorinated biphenyls.","volume":"22","author":"Bohnenberger","year":"2001","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/carcin\/19.7.1173","article-title":"Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.","volume":"19","author":"Gonzales","year":"1998","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1126\/science.1073502","article-title":"Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.","volume":"298","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"2019041123440692200_R32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular carcinoma.","volume":"5","author":"Bruix","year":"2004","journal-title":"Cancer Cell"},{"key":"2019041123440692200_R33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/carcin\/12.6.1009","article-title":"The effect of the format of administration and the total dose of phenobarbital on altered hepatic foci following initiation in female rats with diethylnitrosamine.","volume":"12","author":"Xu","year":"1991","journal-title":"Carcinogenesis"},{"key":"2019041123440692200_R34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R","article-title":"\u03b2-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.","volume":"92","author":"Wong","year":"2001","journal-title":"Cancer"},{"key":"2019041123440692200_R35","first-page":"99","article-title":"Role of connexin32 and \u03b2-catenin in tumor promotion in mouse liver.","volume":"31","author":"Schwarz","year":"2003","journal-title":"Toxicol Pathol"},{"key":"2019041123440692200_R36","first-page":"301","article-title":"Liver-cell adenoma in an epileptic man on barbiturates.","volume":"4","author":"Vazquez","year":"1989","journal-title":"Histol Histopathol"},{"key":"2019041123440692200_R37","first-page":"192","article-title":"[Pigmented hepatocellular adenoma of the liver caused by long-term use of phenobarbital].","volume":"82","author":"Ferko","year":"2003","journal-title":"Rozhl Chir"},{"key":"2019041123440692200_R38","first-page":"294","article-title":"Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.","volume":"55","author":"Olsen","year":"1995","journal-title":"Cancer Res"},{"key":"2019041123440692200_R39","first-page":"5021","article-title":"Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.","volume":"63","author":"Farazi","year":"2003","journal-title":"Cancer Res"},{"key":"2019041123440692200_R40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland.","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041123440692200_R41","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR).","volume":"100","author":"Huang","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041123440692200_R42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1124\/mol.62.5.1177","article-title":"Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor.","volume":"62","author":"Kocarek","year":"2002","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/19\/6\/1646\/10719139\/mend1646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T18:41:24Z","timestamp":1555094484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/19\/6\/1646\/2738214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2004-0520","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}